nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—adipose tissue—Graves' disease	0.0306	0.0967	CbGeAlD
Carfilzomib—Neuritis—Methimazole—Graves' disease	0.0305	0.145	CcSEcCtD
Carfilzomib—PSMB10—thyroid gland—Graves' disease	0.0265	0.0837	CbGeAlD
Carfilzomib—Neuritis—Propylthiouracil—Graves' disease	0.0259	0.123	CcSEcCtD
Carfilzomib—PSMB1—eye—Graves' disease	0.0206	0.0651	CbGeAlD
Carfilzomib—PSMB2—eye—Graves' disease	0.0201	0.0635	CbGeAlD
Carfilzomib—PSMB8—pituitary gland—Graves' disease	0.0198	0.0625	CbGeAlD
Carfilzomib—PSMB8—adipose tissue—Graves' disease	0.0197	0.0623	CbGeAlD
Carfilzomib—PSMB2—connective tissue—Graves' disease	0.0194	0.0612	CbGeAlD
Carfilzomib—PSMB5—pituitary gland—Graves' disease	0.0175	0.0553	CbGeAlD
Carfilzomib—PSMB5—adipose tissue—Graves' disease	0.0174	0.055	CbGeAlD
Carfilzomib—PSMB8—thyroid gland—Graves' disease	0.0171	0.0539	CbGeAlD
Carfilzomib—Hepatic failure—Propylthiouracil—Graves' disease	0.0156	0.0742	CcSEcCtD
Carfilzomib—PSMB1—pituitary gland—Graves' disease	0.0153	0.0483	CbGeAlD
Carfilzomib—Renal failure acute—Propylthiouracil—Graves' disease	0.0152	0.0722	CcSEcCtD
Carfilzomib—PSMB1—adipose tissue—Graves' disease	0.0152	0.0481	CbGeAlD
Carfilzomib—PSMB5—thyroid gland—Graves' disease	0.0151	0.0476	CbGeAlD
Carfilzomib—PSMB2—pituitary gland—Graves' disease	0.0149	0.0471	CbGeAlD
Carfilzomib—PSMB2—adipose tissue—Graves' disease	0.0149	0.0469	CbGeAlD
Carfilzomib—PSMB1—thyroid gland—Graves' disease	0.0132	0.0416	CbGeAlD
Carfilzomib—PSMB2—thyroid gland—Graves' disease	0.0129	0.0406	CbGeAlD
Carfilzomib—Neuropathy peripheral—Methimazole—Graves' disease	0.0125	0.0592	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0106	0.0504	CcSEcCtD
Carfilzomib—Leukopenia—Methimazole—Graves' disease	0.00891	0.0423	CcSEcCtD
Carfilzomib—Arthralgia—Methimazole—Graves' disease	0.00848	0.0402	CcSEcCtD
Carfilzomib—Thrombocytopenia—Methimazole—Graves' disease	0.00795	0.0377	CcSEcCtD
Carfilzomib—Leukopenia—Propylthiouracil—Graves' disease	0.00758	0.0359	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0074	0.0351	CcSEcCtD
Carfilzomib—Arthralgia—Propylthiouracil—Graves' disease	0.00721	0.0342	CcSEcCtD
Carfilzomib—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00676	0.0321	CcSEcCtD
Carfilzomib—Body temperature increased—Methimazole—Graves' disease	0.00642	0.0305	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00629	0.0299	CcSEcCtD
Carfilzomib—Body temperature increased—Propylthiouracil—Graves' disease	0.00546	0.0259	CcSEcCtD
Carfilzomib—Vomiting—Methimazole—Graves' disease	0.00517	0.0245	CcSEcCtD
Carfilzomib—Headache—Methimazole—Graves' disease	0.00509	0.0241	CcSEcCtD
Carfilzomib—Nausea—Methimazole—Graves' disease	0.00483	0.0229	CcSEcCtD
Carfilzomib—Vomiting—Propylthiouracil—Graves' disease	0.00439	0.0208	CcSEcCtD
Carfilzomib—Headache—Propylthiouracil—Graves' disease	0.00433	0.0205	CcSEcCtD
Carfilzomib—Nausea—Propylthiouracil—Graves' disease	0.0041	0.0195	CcSEcCtD
Carfilzomib—ABCB1—pituitary gland—Graves' disease	0.00228	0.0072	CbGeAlD
Carfilzomib—ABCB1—adipose tissue—Graves' disease	0.00227	0.00717	CbGeAlD
Carfilzomib—ABCB1—thyroid gland—Graves' disease	0.00196	0.00621	CbGeAlD
Carfilzomib—PSMB8—Interferon Signaling—HLA-DRB1—Graves' disease	0.00124	0.00263	CbGpPWpGaD
Carfilzomib—PSMB8—Interferon Signaling—ICAM1—Graves' disease	0.00119	0.00253	CbGpPWpGaD
Carfilzomib—PSMB5—HIV Infection—HLA-A—Graves' disease	0.00114	0.0024	CbGpPWpGaD
Carfilzomib—PSMB1—HIV Infection—HLA-A—Graves' disease	0.00114	0.0024	CbGpPWpGaD
Carfilzomib—PSMB2—HIV Infection—HLA-A—Graves' disease	0.00114	0.0024	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.00113	0.00239	CbGpPWpGaD
Carfilzomib—PSMB1—Host Interactions of HIV factors—CD4—Graves' disease	0.00113	0.00238	CbGpPWpGaD
Carfilzomib—PSMB2—Host Interactions of HIV factors—CD4—Graves' disease	0.00113	0.00238	CbGpPWpGaD
Carfilzomib—PSMB5—Host Interactions of HIV factors—CD4—Graves' disease	0.00113	0.00238	CbGpPWpGaD
Carfilzomib—PSMB8—HIV Infection—HLA-A—Graves' disease	0.00112	0.00237	CbGpPWpGaD
Carfilzomib—PSMB8—Host Interactions of HIV factors—CD4—Graves' disease	0.00111	0.00235	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CD40—Graves' disease	0.00111	0.00234	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.00109	0.00231	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.00109	0.00231	CbGpPWpGaD
Carfilzomib—PSMB5—Class I MHC mediated antigen processing & presentation—HLA-B—Graves' disease	0.00108	0.00229	CbGpPWpGaD
Carfilzomib—PSMB2—Class I MHC mediated antigen processing & presentation—HLA-B—Graves' disease	0.00108	0.00229	CbGpPWpGaD
Carfilzomib—PSMB1—Class I MHC mediated antigen processing & presentation—HLA-B—Graves' disease	0.00108	0.00229	CbGpPWpGaD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—HLA-B—Graves' disease	0.00107	0.00226	CbGpPWpGaD
Carfilzomib—PSMB5—Class I MHC mediated antigen processing & presentation—HLA-A—Graves' disease	0.001	0.00212	CbGpPWpGaD
Carfilzomib—PSMB1—Class I MHC mediated antigen processing & presentation—HLA-A—Graves' disease	0.001	0.00212	CbGpPWpGaD
Carfilzomib—PSMB2—Class I MHC mediated antigen processing & presentation—HLA-A—Graves' disease	0.001	0.00212	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GC—Graves' disease	0.001	0.00212	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GC—Graves' disease	0.000998	0.00211	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-E—Graves' disease	0.000993	0.0021	CbGpPWpGaD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—HLA-A—Graves' disease	0.00099	0.00209	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-E—Graves' disease	0.000989	0.00209	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000982	0.00208	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD40—Graves' disease	0.000971	0.00205	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD40—Graves' disease	0.000966	0.00204	CbGpPWpGaD
Carfilzomib—PSMB10—HIV Infection—CD4—Graves' disease	0.000966	0.00204	CbGpPWpGaD
Carfilzomib—PSMB9—HIV Infection—CD4—Graves' disease	0.000961	0.00203	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CTLA4—Graves' disease	0.000957	0.00202	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CTLA4—Graves' disease	0.000952	0.00201	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.00092	0.00195	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.00091	0.00192	CbGpPWpGaD
Carfilzomib—PSMB8—Interferon Signaling—IFNG—Graves' disease	0.000909	0.00192	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—B3GNT2—Graves' disease	0.000908	0.00192	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—B3GNT2—Graves' disease	0.000903	0.00191	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000898	0.0019	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—TNF—Graves' disease	0.000844	0.00179	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—TNF—Graves' disease	0.00084	0.00178	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000831	0.00176	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000806	0.00171	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000798	0.00169	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000788	0.00167	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000788	0.00167	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000784	0.00166	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IFIH1—Graves' disease	0.000766	0.00162	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFIH1—Graves' disease	0.000762	0.00161	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GC—Graves' disease	0.00076	0.00161	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GC—Graves' disease	0.00076	0.00161	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—B3GNT2—Graves' disease	0.00076	0.00161	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GC—Graves' disease	0.00076	0.00161	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—FAS—Graves' disease	0.00076	0.00161	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—B3GNT2—Graves' disease	0.000756	0.0016	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000756	0.0016	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-E—Graves' disease	0.000753	0.00159	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-E—Graves' disease	0.000753	0.00159	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-E—Graves' disease	0.000753	0.00159	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GC—Graves' disease	0.000749	0.00158	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000747	0.00158	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-E—Graves' disease	0.000742	0.00157	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD40—Graves' disease	0.000736	0.00156	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD40—Graves' disease	0.000736	0.00156	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD40—Graves' disease	0.000736	0.00156	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD8A—Graves' disease	0.000736	0.00156	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD8A—Graves' disease	0.000732	0.00155	CbGpPWpGaD
Carfilzomib—PSMB5—HIV Infection—CD4—Graves' disease	0.000732	0.00155	CbGpPWpGaD
Carfilzomib—PSMB2—HIV Infection—CD4—Graves' disease	0.000732	0.00155	CbGpPWpGaD
Carfilzomib—PSMB1—HIV Infection—CD4—Graves' disease	0.000732	0.00155	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD40—Graves' disease	0.000725	0.00153	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CTLA4—Graves' disease	0.000725	0.00153	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CTLA4—Graves' disease	0.000725	0.00153	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CTLA4—Graves' disease	0.000725	0.00153	CbGpPWpGaD
Carfilzomib—PSMB8—HIV Infection—CD4—Graves' disease	0.000722	0.00153	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CTLA4—Graves' disease	0.000715	0.00151	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-B—Graves' disease	0.000708	0.0015	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-B—Graves' disease	0.000704	0.00149	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—B3GNT2—Graves' disease	0.000688	0.00145	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—B3GNT2—Graves' disease	0.000688	0.00145	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—B3GNT2—Graves' disease	0.000688	0.00145	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000683	0.00144	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—B3GNT2—Graves' disease	0.000678	0.00143	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-A—Graves' disease	0.000656	0.00139	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-A—Graves' disease	0.000653	0.00138	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TNF—Graves' disease	0.00064	0.00135	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TNF—Graves' disease	0.00064	0.00135	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TNF—Graves' disease	0.00064	0.00135	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TNF—Graves' disease	0.000631	0.00133	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000607	0.00128	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-E—Graves' disease	0.000602	0.00127	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-E—Graves' disease	0.0006	0.00127	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000599	0.00127	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000597	0.00126	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000597	0.00126	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000597	0.00126	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000596	0.00126	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD40—Graves' disease	0.000589	0.00125	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000589	0.00125	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD40—Graves' disease	0.000586	0.00124	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CTLA4—Graves' disease	0.00058	0.00123	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFIH1—Graves' disease	0.00058	0.00123	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFIH1—Graves' disease	0.00058	0.00123	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFIH1—Graves' disease	0.00058	0.00123	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CTLA4—Graves' disease	0.000578	0.00122	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—B3GNT2—Graves' disease	0.000576	0.00122	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—B3GNT2—Graves' disease	0.000576	0.00122	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—B3GNT2—Graves' disease	0.000576	0.00122	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ICAM1—Graves' disease	0.000575	0.00122	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ICAM1—Graves' disease	0.000572	0.00121	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFIH1—Graves' disease	0.000572	0.00121	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—B3GNT2—Graves' disease	0.000568	0.0012	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD8A—Graves' disease	0.000558	0.00118	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD8A—Graves' disease	0.000558	0.00118	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD8A—Graves' disease	0.000558	0.00118	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD8A—Graves' disease	0.00055	0.00116	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000542	0.00115	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-B—Graves' disease	0.000536	0.00113	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-B—Graves' disease	0.000536	0.00113	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-B—Graves' disease	0.000536	0.00113	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-B—Graves' disease	0.000529	0.00112	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TSHR—Graves' disease	0.000527	0.00111	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TSHR—Graves' disease	0.000524	0.00111	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000499	0.00105	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-A—Graves' disease	0.000497	0.00105	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-A—Graves' disease	0.000497	0.00105	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-A—Graves' disease	0.000497	0.00105	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-A—Graves' disease	0.00049	0.00104	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-DQB1—Graves' disease	0.000478	0.00101	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-DQB1—Graves' disease	0.000476	0.00101	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-E—Graves' disease	0.000457	0.000966	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-E—Graves' disease	0.000457	0.000966	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-E—Graves' disease	0.000457	0.000966	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000454	0.00096	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000454	0.00096	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000454	0.00096	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-E—Graves' disease	0.00045	0.000952	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000448	0.000947	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD40—Graves' disease	0.000446	0.000944	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD40—Graves' disease	0.000446	0.000944	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD8A—Graves' disease	0.000446	0.000944	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD40—Graves' disease	0.000446	0.000944	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000445	0.000941	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD8A—Graves' disease	0.000444	0.000939	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000444	0.000939	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD40—Graves' disease	0.00044	0.000931	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CTLA4—Graves' disease	0.00044	0.00093	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CTLA4—Graves' disease	0.00044	0.00093	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CTLA4—Graves' disease	0.00044	0.00093	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ICAM1—Graves' disease	0.000436	0.000922	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ICAM1—Graves' disease	0.000436	0.000922	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ICAM1—Graves' disease	0.000436	0.000922	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CTLA4—Graves' disease	0.000434	0.000917	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ICAM1—Graves' disease	0.00043	0.000909	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-B—Graves' disease	0.000429	0.000908	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-B—Graves' disease	0.000427	0.000904	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD4—Graves' disease	0.000423	0.000894	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD4—Graves' disease	0.000421	0.00089	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL2RA—Graves' disease	0.000402	0.000851	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2RA—Graves' disease	0.0004	0.000847	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TSHR—Graves' disease	0.000399	0.000844	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TSHR—Graves' disease	0.000399	0.000844	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TSHR—Graves' disease	0.000399	0.000844	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-A—Graves' disease	0.000398	0.000841	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-A—Graves' disease	0.000396	0.000837	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TSHR—Graves' disease	0.000393	0.000832	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000389	0.000823	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000375	0.000793	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—HLA-A—Graves' disease	0.000367	0.000777	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—HLA-A—Graves' disease	0.000365	0.000773	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-DRB1—Graves' disease	0.000363	0.000769	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DQB1—Graves' disease	0.000362	0.000766	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DQB1—Graves' disease	0.000362	0.000766	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DQB1—Graves' disease	0.000362	0.000766	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-DRB1—Graves' disease	0.000362	0.000765	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DQB1—Graves' disease	0.000357	0.000755	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ICAM1—Graves' disease	0.000349	0.000738	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ICAM1—Graves' disease	0.000347	0.000734	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL10—Graves' disease	0.00034	0.00072	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL10—Graves' disease	0.000339	0.000716	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD8A—Graves' disease	0.000338	0.000715	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD8A—Graves' disease	0.000338	0.000715	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD8A—Graves' disease	0.000338	0.000715	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD8A—Graves' disease	0.000333	0.000705	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-B—Graves' disease	0.000325	0.000688	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-B—Graves' disease	0.000325	0.000688	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-B—Graves' disease	0.000325	0.000688	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000323	0.000683	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-B—Graves' disease	0.000321	0.000678	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD4—Graves' disease	0.00032	0.000677	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD4—Graves' disease	0.00032	0.000677	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD4—Graves' disease	0.00032	0.000677	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD4—Graves' disease	0.000316	0.000668	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2RA—Graves' disease	0.000305	0.000645	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2RA—Graves' disease	0.000305	0.000645	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2RA—Graves' disease	0.000305	0.000645	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-A—Graves' disease	0.000301	0.000638	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-A—Graves' disease	0.000301	0.000638	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-A—Graves' disease	0.000301	0.000638	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2RA—Graves' disease	0.000301	0.000636	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-A—Graves' disease	0.000297	0.000629	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—HLA-A—Graves' disease	0.000278	0.000589	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—HLA-A—Graves' disease	0.000278	0.000589	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—HLA-A—Graves' disease	0.000278	0.000589	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DRB1—Graves' disease	0.000275	0.000583	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DRB1—Graves' disease	0.000275	0.000583	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DRB1—Graves' disease	0.000275	0.000583	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—HLA-A—Graves' disease	0.000274	0.00058	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DRB1—Graves' disease	0.000272	0.000574	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IFNG—Graves' disease	0.000265	0.000561	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ICAM1—Graves' disease	0.000264	0.000559	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ICAM1—Graves' disease	0.000264	0.000559	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ICAM1—Graves' disease	0.000264	0.000559	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFNG—Graves' disease	0.000264	0.000559	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ICAM1—Graves' disease	0.000261	0.000551	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2RA—Graves' disease	0.00026	0.00055	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2RA—Graves' disease	0.000259	0.000547	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL10—Graves' disease	0.000258	0.000545	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL10—Graves' disease	0.000258	0.000545	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL10—Graves' disease	0.000258	0.000545	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—Graves' disease	0.000256	0.000542	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—Graves' disease	0.000255	0.00054	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL10—Graves' disease	0.000254	0.000538	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL1B—Graves' disease	0.000237	0.000501	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—Graves' disease	0.000237	0.000501	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL1B—Graves' disease	0.000236	0.000498	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—Graves' disease	0.000236	0.000498	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GC—Graves' disease	0.000224	0.000473	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—Graves' disease	0.000201	0.000425	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—Graves' disease	0.000201	0.000425	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—Graves' disease	0.000201	0.000425	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—Graves' disease	0.000198	0.000419	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2RA—Graves' disease	0.000197	0.000417	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2RA—Graves' disease	0.000197	0.000417	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2RA—Graves' disease	0.000197	0.000417	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2RA—Graves' disease	0.000194	0.000411	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—Graves' disease	0.000194	0.000411	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—Graves' disease	0.000194	0.000411	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—Graves' disease	0.000194	0.000411	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—Graves' disease	0.000192	0.000405	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—Graves' disease	0.000179	0.000379	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—Graves' disease	0.000179	0.000379	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—Graves' disease	0.000179	0.000379	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—Graves' disease	0.000179	0.000379	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—Graves' disease	0.000179	0.000379	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—Graves' disease	0.000179	0.000379	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—Graves' disease	0.000177	0.000374	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—Graves' disease	0.000177	0.000374	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—B3GNT2—Graves' disease	0.000169	0.000358	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000159	0.000337	CbGpPWpGaD
